‘Suboptimal’ relationship between NHS and pharma needs ‘urgent’ attention, says ex-NICE chief
The relationship between the NHS and the pharmaceutical sector is ‘suboptimal’ because of the misalignment of ‘ambitions, constraints and risk appetites’, according to former National Institute for Health and Care Excellence Sir Andrew Dillon.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- 10 expert briefings every fortnight (Premium only)
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)
Already a subscriber? Sign into your account here